Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Theriva Biologics Inc (TOVX)

Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theriva Biologics Inc 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 USA

www.therivabio.com Employees: 22 P: 301-417-4364

Description:

Theriva Biologics Inc. is a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need. The Company's lead candidate includes VCN-01, SYN-004 and SYN-020. Theriva Biologics Inc., formerly known as Synthetic Biologics Inc., is based in ROCKVILLE, Md.

Key Statistics

Overview:

Market Capitalization, $K 3,068
Enterprise Value, $K -17,222
Shares Outstanding, K 2,273
Annual Sales, $ 0 K
Annual Net Income, $ -18,350 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,320 K
EBIT, $ -20,250 K
EBITDA, $ -20,110 K
60-Month Beta 1.34
% of Insider Shareholders 3.05%
% of Institutional Shareholders 6.17%
Float, K 2,203
% Float 96.95%
Short Volume Ratio 0.41

Growth:

1-Year Return -86.67%
3-Year Return -98.50%
5-Year Return -98.65%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.19%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -6.81 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -25.75
EPS Growth vs. Prev Qtr -23.82%
EPS Growth vs. Prev Year -43.37%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/26/24

TOVX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -76.12%
Return-on-Assets % -48.54%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.13
Book Value/Share 647.50
Interest Coverage -1.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar